• Aucun résultat trouvé

Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy

N/A
N/A
Protected

Academic year: 2021

Partager "Regulatory T cell frequency, but not plasma IL-33 levels, represents potential immunological biomarker to predict clinical response to intravenous immunoglobulin therapy"

Copied!
9
0
0

Texte intégral

Références

Documents relatifs

Importantly, these patients also showed signifi- cant increase in plasma IL-33 following IVIg therapy (Fig. 1b) thus confirming the results obtained with cohort 1 patients..

The treatment consists in the intravenous injection of cetuximab saratolacan, which binds to head and neck cancer cells expressing high levels of EGFR, followed by illumination of

Despite promising clinical trials, intravenous immunoglobulin (IVIg) therapy in relapsing-remitting multiple sclerosis has met with uncertainties that might be

The elevated levels of DAMPs (such as HMGB1, S100A8 and S100A9) released from stressed cells, and G-CSF, released from vascular endothelial cells and smooth muscle cells,

The pump design uses a bellows with force feedback calibration to pump 1 liter of fluid over 5 minutes and mix the concentrated 90% form with saline without

LES TROUBLES DE L’ÉJACULATION, ORGASME Parmi les autres problèmes de dysfonction sexuelle mas- culine (DSM) on retrouve les troubles de l’éjaculation dont le plus fréquent

Thus, highly cytotoxic radi- ation directed to the relevant tumor cell deposits holds the promise of adding substantially to hitherto failing curative adju- vant chemotherapy both

Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (Resynchronization reVErses